{
    "clinical_study": {
        "@rank": "127594", 
        "acronym": "P1S1", 
        "arm_group": [
            {
                "arm_group_label": "0.8 mg nicotine with 9 mg tar", 
                "arm_group_type": "Experimental", 
                "description": "very low nicotine content cigarettes\nSPECTRUM Cigarette: 0.8 (\u00b10.15) mg nicotine with 9 (\u00b11.5) mg tar (standard nicotine and tar yields of commercially-available cigarettes; control condition)"
            }, 
            {
                "arm_group_label": "0.26 mg nicotine with 9 mg tar", 
                "arm_group_type": "Experimental", 
                "description": "very low nicotine content cigarettes\nSPECTRUM Cigarette: 0.26 (\u00b10.06) mg nicotine with 9 (\u00b11.5) mg tar"
            }, 
            {
                "arm_group_label": "0.12 mg nicotine with 9 mg tar", 
                "arm_group_type": "Experimental", 
                "description": "very low nicotine content cigarettes\nSPECTRUM Cigarette: 0.12 (\u00b10.03) mg nicotine with 9 (\u00b11.5) mg tar"
            }, 
            {
                "arm_group_label": "0.07 mg nicotine with 9 mg tar", 
                "arm_group_type": "Experimental", 
                "description": "very low nicotine content cigarettes\nSPECTRUM Cigarette: 0.07 (\u00b10.02) mg nicotine with 9 (\u00b11.5) mg tar"
            }, 
            {
                "arm_group_label": "0.03 mg nicotine with 9 mg tar", 
                "arm_group_type": "Experimental", 
                "description": "very low nicotine content cigarettes\nSPECTRUM Cigarette: 0.03 (\u00b10.01) mg nicotine with 9 (\u00b11.5) mg tar"
            }, 
            {
                "arm_group_label": "0.04 mg nicotine with 13 mg tar", 
                "arm_group_type": "Experimental", 
                "description": "very low nicotine content cigarettes\nSPECTRUM Cigarette: 0.04 (\u00b10.02) mg nicotine with 13 (\u00b12) mg tar"
            }, 
            {
                "arm_group_label": "Usual brand", 
                "arm_group_type": "Other", 
                "description": "very low nicotine content cigarettes\nUsual brand cigarettes (control condition)"
            }
        ], 
        "brief_summary": {
            "textblock": "Project 1, Study 1 will evaluate the relationship between nicotine yield of very low\n      nicotine content cigarettes and cigarettes smoked per day, nicotine exposure,\n      discomfort/dysfunction, other health-related behaviors, nicotine/tobacco dependence,\n      biomarkers of tobacco exposure, intention to quit, compensatory smoking, other tobacco use,\n      cigarette characteristics, cognitive function, cardiovascular function, and perceived risk.\n      We will also consider differences between conditions in compliance with product use."
        }, 
        "brief_title": "Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Tobacco Dependence", 
        "condition_browse": {
            "mesh_term": "Tobacco Use Disorder"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18+\n\n          -  Smoke an average of at least five cigarettes per day for at least 1 year\n\n          -  Breath CO levels > 8 ppm (if \u2264 8 ppm, then NicAlert Strip > 2)\n\n        Exclusion Criteria:\n\n          -  Intention to quit smoking in the next 30 days\n\n          -  Currently seeking treatment for smoking cessation\n\n          -  Currently using nicotine replacement therapies or other pharmacotherapies as\n             cessation aid (intermittent use acceptable)\n\n          -  A quit attempt in the past 30 days resulting in greater than 3 days of abstinence\n\n          -  Using other tobacco products more than 9 days in the past 30 days\n\n          -  Significant unstable medical conditions (Any significant change in a serious medical\n             condition occurring during the past 3 months including, cardiovascular disease, COPD,\n              and cancer, as determined by the licensed medical professional at each site)\n\n          -  Significant unstable psychiatric conditions (Any significant change in psychiatric\n             symptoms during the past 3 months as determined by the licensed medical professional\n             at each site)\n\n          -  Schizophrenia and schizoaffective disorder\n\n          -  Psychiatric medication changes in the past 3 months\n\n          -  Positive toxicology screen for any of the following drugs: cocaine, opiates,\n             methadone, benzodiazepines, barbiturates, amphetamines, methamphetamines, and PCP\n\n               1. Marijuana will be tested for but will not be an exclusionary criterion.\n\n               2. Participants with valid prescriptions for opiates, benzodiazepines,\n                  barbiturates, amphetamines or methadone will not be excluded.\n\n               3. Participants failing the toxicology screen will be allowed to re-screen once.\n\n          -  Blood alcohol level > 0.01\n\n             a. Participants failing the blood alcohol screen will be allowed to re-screen once.\n\n          -  Binge drinking alcohol (more than 9 days in the past 30 days, 4/5 in a 2 hour\n             period(female/male))\n\n          -  Pregnant or breastfeeding\n\n          -  Smoking 'roll your own cigarettes' exclusively\n\n          -  Currently taking anticonvulsant medication\n\n          -  CO reading >80 ppm\n\n          -  Systolic BP greater than or equal to 160\n\n             a. Participants failing for blood pressure will be allowed to re-screen once.\n\n          -  Diastolic BP greater than or equal to 100\n\n             a. Participants failing for blood pressure will be allowed to re-screen once.\n\n          -  Systolic BP below 90\n\n             a. Participants failing for blood pressure will be allowed to re-screen once.\n\n          -  Diastolic BP below 50\n\n             a. Participants failing for blood pressure will be allowed to re-screen once.\n\n          -  Heart rate greater than or equal to 115bpm\n\n             a. Participants failing for heart rate will be allowed to re-screen once.\n\n          -  Heart rate lower than 45bpm\n\n             a. Participants failing for heart rate will be allowed to re-screen once.\n\n          -  Indicating any suicidal ideation in the past month or suicide attempts in the past 10\n             years\n\n          -  Inability to independently read and comprehend the consent form and other written\n             study materials and measures\n\n          -  Having participated in a research study during the past three months in which the\n             participant:\n\n               1. Smoked a cigarette that was not his/her usual brand cigarette for more than one\n                  day\n\n               2. Used any tobacco products beyond normal use for more than one day\n\n               3. Used any nicotine replacement products or smoking cessation medications for more\n                  than one day"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "840", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01681875", 
            "org_study_id": "U54 DA031659", 
            "secondary_id": "U54DA031659-01"
        }, 
        "intervention": {
            "arm_group_label": [
                "0.8 mg nicotine with 9 mg tar", 
                "0.26 mg nicotine with 9 mg tar", 
                "0.12 mg nicotine with 9 mg tar", 
                "0.07 mg nicotine with 9 mg tar", 
                "0.03 mg nicotine with 9 mg tar", 
                "0.04 mg nicotine with 13 mg tar", 
                "Usual brand"
            ], 
            "intervention_name": "very low nicotine content cigarettes", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Biomarkers of exposure", 
            "Compensatory smoking", 
            "Nicotine dependence", 
            "Reduced nicotine cigarettes", 
            "Tobacco withdrawal"
        ], 
        "lastchanged_date": "May 27, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Natalie Nardone, PhD", 
                    "phone": "415-514-1450"
                }, 
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94143"
                    }, 
                    "name": "University of California San Francisco"
                }, 
                "investigator": {
                    "last_name": "Neal Benowitz, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33617"
                    }, 
                    "name": "Moffitt Cancer Center"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Joseph Harrison, MS", 
                    "phone": "410-550-3073"
                }, 
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21224"
                    }, 
                    "name": "Johns Hopkins University"
                }, 
                "investigator": [
                    {
                        "last_name": "Maxine Stitzer, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Ryan Vandrey, PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duluth", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55812"
                    }, 
                    "name": "University of Minnesota Medical School Duluth"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55414"
                    }, 
                    "name": "University of Minnesota Masonic Cancer Center"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Rachel Kozink", 
                    "phone": "919-668-2963"
                }, 
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27705"
                    }, 
                    "name": "Duke University"
                }, 
                "investigator": {
                    "last_name": "Francis J McClernon, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Kathy Tang", 
                    "phone": "215-746-7146"
                }, 
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "University of Pennsylvania"
                }, 
                "investigator": {
                    "last_name": "Andrew Strasser, Ph.D", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15260"
                    }, 
                    "name": "University of Pittsburgh"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Netesha Reid", 
                    "phone": "401-863-6463"
                }, 
                "contact_backup": {
                    "last_name": "Emily Xavier", 
                    "phone": "401-863-6463"
                }, 
                "facility": {
                    "address": {
                        "city": "Providence", 
                        "country": "United States", 
                        "state": "Rhode Island", 
                        "zip": "02912"
                    }, 
                    "name": "Brown University"
                }, 
                "investigator": {
                    "last_name": "Jennifer Tidey, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "7", 
        "official_title": "Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes", 
        "overall_contact": {
            "email": "rld9@pitt.edu", 
            "last_name": "Rachel L Denlinger, B.S", 
            "phone": "412-624-7865"
        }, 
        "overall_contact_backup": {
            "email": "tjd50@pitt.edu", 
            "last_name": "Tonya Lane, M.Ed.", 
            "phone": "412-624-6179"
        }, 
        "overall_official": {
            "affiliation": "University of Pittsburgh", 
            "last_name": "Eric C Donny, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Data and Safety Monitoring Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of cigarettes smoked per day", 
            "safety_issue": "No", 
            "time_frame": "End of 6 week intervention"
        }, 
        "reference": [
            {
                "PMID": "19446968", 
                "citation": "Donny EC, Jones M. Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine. Drug Alcohol Depend. 2009 Sep 1;104(1-2):23-33. Epub 2009 May 15."
            }, 
            {
                "PMID": "20078491", 
                "citation": "Hatsukami DK, Kotlyar M, Hertsgaard LA, Zhang Y, Carmella SG, Jensen JA, Allen SS, Shields PG, Murphy SE, Stepanov I, Hecht SS. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction. 2010 Feb;105(2):343-55. doi: 10.1111/j.1360-0443.2009.02780.x."
            }, 
            {
                "PMID": "22354905", 
                "citation": "Benowitz NL, Dains KM, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P 3rd. Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):761-9. Epub 2012 Feb 21."
            }, 
            {
                "PMID": "17222288", 
                "citation": "Donny EC, Houtsmuller E, Stitzer ML. Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction. 2007 Feb;102(2):324-34."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01681875"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Pittsburgh", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "National Institute on Drug Abuse (NIDA)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "Masonic Cancer Center, University of Minnesota", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Brown University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Johns Hopkins University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of California, San Francisco", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "M.D. Anderson Cancer Center", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Pennsylvania", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Duke University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "H. Lee Moffitt Cancer Center and Research Institute", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Minnesota - Clinical and Translational Science Institute", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Pittsburgh", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}